Radiomics Approach Outperforms Diameter Criteria for Predicting Pathological Lateral Lymph Node Metastasis After Neoadjuvant (Chemo)Radiotherapy in Advanced Low Rectal CancerRyota Nakanishi, Hiroya Kuroyanagi, Yutaka Hanaoka et al.|Annals of Surgical Oncology|2020Cited by 74
Non-operative management after chemoradiotherapy plus consolidation or sandwich (induction with bevacizumab and consolidation) chemotherapy in patients with locally advanced rectal cancer: a multicentre, randomised phase II trial (NOMINATE trial)Takashi Akiyoshi, Tsuyoshi Konishi, Eiji Shinozaki et al.|BMJ Open|2022Cited by 14
ctDNA Longitudinal Analysis during Total Neoadjuvant Therapy and Nonoperative Management for Locally Advanced Rectal Cancer: A Biomarker Study from the NOMINATE TrialTakashi Akiyoshi, Kensei Yamaguchi, Eiji Shinozaki et al.|Clinical Cancer Research|2025Cited by 13
Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection for Patients with Poor-Risk, Locally Advanced, Mid-to-Low Rectal Cancer May Improve Oncologic Outcomes: A Propensity Score-Matched AnalysisTomohiro Yamaguchi, Tsuyoshi Konishi, Takashi Akiyoshi et al.|Annals of Surgical Oncology|2023Cited by 11
Features of Lateral Pelvic Lymph Nodes Associated With Pathological Involvement After Total Neoadjuvant Therapy in Patients Undergoing Lateral Pelvic Lymph Node DissectionTatsuki Noguchi, Yosuke Fukunaga, Takashi Akiyoshi et al.|Diseases of the Colon & Rectum|2024Cited by 5